Group 1 - The stock of Xiangsheng Medical (688358) closed at 30.74 yuan on December 5, 2025, with an increase of 1.12% and a trading volume of 4319 lots, amounting to 13.20 million yuan [1] - The net capital flow on December 5 showed a net outflow of 352,700 yuan from main funds, accounting for 2.67% of the total trading volume, while retail funds had a net inflow of 870,100 yuan, representing 6.59% of the total [1] - Over the past five days, the stock experienced fluctuations in capital flow, with varying net inflows and outflows from main, retail, and speculative funds [2] Group 2 - Xiangsheng Medical's total market value is 3.447 billion yuan, with a net asset value of 1.4 billion yuan and a net profit of 93.92 million yuan, ranking 94th, 90th, and 49th respectively in the medical device industry [3] - The company reported a year-on-year decline in main revenue of 5.27% for the first three quarters of 2025, with a net profit decrease of 4.56% [3] - The gross profit margin stands at 59.82%, significantly higher than the industry average of 51.22%, while the net profit margin is 27.37%, compared to the industry average of 9.57% [3] Group 3 - Three institutions have given buy ratings for Xiangsheng Medical in the last 90 days, indicating positive sentiment towards the stock [4] - The definitions of capital flow indicate that inflows are associated with price increases driven by active buying, while outflows are linked to price declines due to active selling [5]
股票行情快报:祥生医疗(688358)12月5日主力资金净卖出35.27万元